Skip to content

A clinical trial to study the effects of two drugs, Shatavari Guggulu and Trayodashanga Guggulu in patients with Janusandhigata Vata(Osteoarthritis of Knee)

A Randomised Controlled Clinical Study to evaluate the efficacy of Shatavari Guggulu in Janusandhigata Vata.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/07/044162
Enrollment
60
Registered
2022-07-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

None listed

Sponsors

Dr Swathilakshmi P S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients showing the classical Lakshana of Janusandhigata Vata like Sandhi Shotha , Sandhi Shoola and Prasarana Akunchana Vedana; with or without Atopa ,Stambha and Vata Poorna Druthisparsha. Patients diagnosed with Janusandhigata Vata. Patients of either sex between 30 â?? 70 years of age. Subjects who are willing to participate and sign in the informed consent form.

Exclusion criteria

Exclusion criteria: Subjects suffering from diseases like Amavata, Vatarakta or any other systemic disorders. Secondary Osteoarthritis of Knee. Subjects with deformities like Genu varum and Genu valgum. Subjects who require surgical interventions. Subjects who are under Intra-Articular injection of Corticosteroid during 3 months preceding enrolment. Pregnant women and Lactating mother.

Design outcomes

Primary

MeasureTime frame
The effect of the treatment will be assessed based on detailed case proforma adopting standard scoring methods of subjective parameters such as Janu Sandhi Shoola, Janu Sandhi Stambha and objective parameters such as Janu Sandhi Shotha, Janu Sandhi Atopa, Janu Sandhi Prasarana and Akunchana Vedana, Tenderness, Visual Analogue Scale (VAS), WOMAC O.A Index. Pre and Post interventional assessment will be done.Timepoint: The effect of the treatment will be assessed on 16th day, 31st day and 46th day.

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Susheel Shetty

Alvas ayurveda medical college

shettysusheel13@gmail.com9980431676

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026